Vilin Bio Med Limited (NSE:VILINBIO)
India · Delayed Price · Currency is INR 44.35
-0.85 (-1.88%)
Jun 17, 2026, 11:14 AM IST
Vilin Bio Med Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 422.63 | 148.1 | 158.05 | 123.13 | 112.15 |
Other Revenue | -0 | - | - | 0.24 | 0.04 |
| 422.63 | 148.1 | 158.05 | 123.37 | 112.19 | |
Revenue Growth (YoY) | 185.37% | -6.30% | 28.11% | 9.97% | -4.26% |
Cost of Revenue | 376.27 | 134.9 | 130.31 | 72.64 | 89.77 |
Gross Profit | 46.36 | 13.2 | 27.74 | 50.74 | 22.42 |
Selling, General & Admin | 7.41 | 2.95 | 8.07 | 7.77 | 8.57 |
Other Operating Expenses | 7.01 | 2.38 | 11.51 | 16.99 | 6.15 |
Operating Expenses | 17.27 | 6.38 | 20.88 | 26.44 | 16.92 |
Operating Income | 29.08 | 6.83 | 6.87 | 24.3 | 5.51 |
Interest Expense | -0.69 | -8.45 | -7.8 | -6.49 | -4.95 |
Interest & Investment Income | - | 4.69 | 3.24 | - | - |
Other Non Operating Income (Expenses) | 0.01 | -0 | -0.05 | 0 | -0.11 |
Pretax Income | 28.41 | 3.06 | 2.25 | 17.82 | 0.45 |
Income Tax Expense | 9.12 | 0.82 | 0.63 | 5.37 | 0.11 |
Net Income | 19.29 | 2.24 | 1.62 | 12.45 | 0.34 |
Net Income to Common | 19.29 | 2.24 | 1.62 | 12.45 | 0.34 |
Net Income Growth | 763.00% | 37.62% | -86.96% | 3605.36% | -72.30% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 10 | 8 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 10 | 8 |
Shares Change (YoY) | 0.92% | - | 40.20% | 20.61% | - |
EPS (Basic) | 1.37 | 0.16 | 0.12 | 1.25 | 0.04 |
EPS (Diluted) | 1.37 | 0.16 | 0.12 | 1.25 | 0.04 |
EPS Growth | 756.25% | 37.44% | -90.69% | 3025.00% | -72.80% |
Free Cash Flow | 4.01 | -13.57 | -74.22 | -16.88 | 2.09 |
Free Cash Flow Per Share | 0.28 | -0.97 | -5.32 | -1.70 | 0.25 |
Gross Margin | 10.97% | 8.91% | 17.55% | 41.13% | 19.98% |
Operating Margin | 6.88% | 4.61% | 4.34% | 19.70% | 4.91% |
Profit Margin | 4.56% | 1.51% | 1.03% | 10.09% | 0.30% |
Free Cash Flow Margin | 0.95% | -9.16% | -46.96% | -13.68% | 1.86% |
EBITDA | 31.93 | 7.87 | 8.17 | 25.98 | 7.7 |
EBITDA Margin | 7.56% | 5.31% | 5.17% | 21.05% | 6.86% |
D&A For EBITDA | 2.85 | 1.04 | 1.3 | 1.68 | 2.19 |
EBIT | 29.08 | 6.83 | 6.87 | 24.3 | 5.51 |
EBIT Margin | 6.88% | 4.61% | 4.34% | 19.70% | 4.91% |
Effective Tax Rate | 32.11% | 26.91% | 27.85% | 30.12% | 24.83% |
Revenue as Reported | 422.64 | 152.78 | 161.29 | 123.37 | 112.19 |
Advertising Expenses | - | - | 0.03 | - | 0.08 |